I.M. Nilsson
Impact in
- Hematology top 10%
- Platelet Disorders and Treatments
- Hemophilia Treatment and Research
- Blood Coagulation and Thrombosis Mechanisms
- Blood groups and transfusion
-
- Breast Cancer Treatment Studies
- Protease and Inhibitor Mechanisms
Papers in
-
- Hemophilia Treatment and Research 3
- Platelet Disorders and Treatments 3
- Blood Coagulation and Thrombosis Mechanisms 3
- Blood groups and transfusion 2
- Genetics 7
- Estrogen and related hormone effects 4
- Co-authors
- Birger Åstedt (3 shared papers)Lars Holmberg (4 shared papers)Gösta Rooth (1 shared paper)L Svanberg (1 shared paper)Gunnar Westman (3 shared papers)Hans Modig (3 shared papers)S Borgström (2 shared papers)A.J. Montandon (1 shared paper)
In The Last Decade
I.M. Nilsson
20 papers receiving 327 citations
Peers
Comparison fields: 5 of 61
- Hematology 126
- Cancer Research 84
- Genetics 115
- Genetics 36
- Oncology 74
Countries citing papers authored by I.M. Nilsson
This map shows the geographic impact of I.M. Nilsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I.M. Nilsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I.M. Nilsson more than expected).
Fields of papers citing papers by I.M. Nilsson
This network shows the impact of papers produced by I.M. Nilsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I.M. Nilsson. The network helps show where I.M. Nilsson may publish in the future.
Co-authors
The 25 scholars most cited alongside I.M. Nilsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 83 | |
| 2 | 1971 | 50 | |
| 3 | STUDIES ON FOETAL AND MATERNAL METABOLIC ACIDOSIS. | 1964 | 35 |
| 4 | 1990 | 29 | |
| 5 | 1987 | 28 | |
| 6 | 1975 | 26 | |
| 7 | Phase II study of high dose toremifene in advanced breast cancer progressing during tamoxifene treatment. | 1991 | 19 |
| 8 | 1990 | 17 | |
| 9 | 1988 | 15 | |
| 10 | 1974 | 14 | |
| 11 | 1971 | 11 | |
| 12 | Cloning and characterization of 5'-end alternatively spliced human cholecystokinin-B receptor mRNAs. | 1998 | 11 |
| 13 | 1978 | 10 | |
| 14 | 1993 | 10 | |
| 15 | 1990 | 9 | |
| 16 | 1971 | 8 | |
| 17 | 1985 | 5 | |
| 18 | 1977 | 3 | |
| 19 | 2008 | 2 | |
| 20 | 1989 | 2 |
About I.M. Nilsson
I.M. Nilsson is a scholar working on Hematology, Genetics, Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 387 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (4 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Hemophilia Treatment and Research (3 papers), Cancer Treatment and Pharmacology (3 papers), Platelet Disorders and Treatments (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Blood groups and transfusion (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Hematology (126 citations), Cancer Research (84 citations), Genetics (115 citations), Genetics (36 citations) and Oncology (74 citations). I.M. Nilsson has collaborated with scholars based in Sweden, Norway and Finland. Frequent co-authors include Birger Åstedt, Lars Holmberg, Gösta Rooth, L Svanberg, Gunnar Westman, Hans Modig, S Borgström, A.J. Montandon, Jouni Vuorinen and Seppo Pyrhönen. Their work appears in journals such as Thrombosis and Haemostasis, British Journal of Haematology, Human Genetics, Acta Oncologica and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.